-
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Rating of "Buy" from Analysts
Source: Buzz FX / 18 Oct 2024 05:16:13 America/New_York
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Rating of "Buy" from Analysts Written by MarketBeat October 18, 2024 Share Link copied to clipboard. Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX - Get Free Report ) has receiv
Read more...